REGENERAR Project Showcased at Encontro Ciência 2024

The REGENERAR project gained significant attention at the “Encontro Ciência 2024” (“Science Meeting 2024”), a major platform for scientific dialogue and exchange held at the Alfândega Porto Congress Centre from July 3rd to 5th. This year’s event, organized by the Foundation for Science and Technology, featured a wide range of scientific activities and discussions under the theme “+Science for One Health and Global Well-Being.”
REGENERAR Project Highlights Innovations in Drug Delivery and Gene Editing at TERMIS World Congress

Professor Lino Ferreira made a significant impact at the 2024 TERMIS World Congress, held from June 25-28, 2024, at the Seattle Convention Center in Seattle, Washington, USA. The event, co-chaired by Dr. Nasim Annabi and Dr. Elizabeth Cosgriff-Hernandez, brought together over 1,000 experts and researchers from around the globe to discuss advancements in tissue engineering and regenerative medicine.
Professor Lino Ferreira and Susana Simões Present REGENERAR at the 10th Iberian Colloids and Interfaces Meeting

At the 10th Iberian Meeting on Colloids and Interfaces, held at the University of Coimbra, Portugal, from June 23-26, 2024, over 150 researchers and scientists gathered to explore the latest advancements in colloids and interfaces. The event, chaired by Dr. Artur Valente, showcased pioneering research in nanotechnology and biotechnology.
REGENERAR Showcased at 2nd MIA Portugal Ageing Spring School 2024

The REGENERAR project was prominently featured at the 2nd MIA Portugal Ageing Spring School 2024, held from May 27-29 in Coimbra. This three-day event brought together leading experts in the field of ageing to discuss the latest research and developments, fostering meaningful exchanges on how to tackle the challenges associated with ageing.
REGENERAR project highlights innovative advances at Nanotechnology in Medicine IV Conference

In May 2024, Dr. Lino Ferreira, coordinator of the REGENERAR project at the University of Coimbra, participated in the Nanotechnology in Medicine IV: Physical Triggers and Advanced Materials for Translation conference held in Tomar, Portugal, from May 12-16. The conference, organized by Engineering Conferences International, serves as a prominent platform for exploring cutting-edge issues in nanotechnology and advanced materials.
REGENERAR Engages Students in Hands-On Science at Ferrer Correia School

The REGENERAR project, an innovative initiative funded by Horizon Europe, recently hosted an engaging activity at Escola EBI/JI Prof. Dr. Ferrer Correia as part of the school’s Science Week. On May 9, 2024, collaborators Inês Tomé Ribeiro and Simão Correia Santos led a 90-minute session for 17 ninth-grade students, aiming to bring science closer to young minds through interactive and educational activities.
REGENERAR Engages Future Scientists in Brain Repair and Neurological Disorders

As part of its mission to advance public understanding and engagement in groundbreaking scientific research, the Horizon Europe-funded REGENERAR project recently reached out to young minds at Escola Secundária da Lousã. On April 24, 2024, Inês Tomé Ribeiro, a collaborator on the REGENERAR project, participated in a job fair at the school, where she introduced high school students to the world of advanced therapies and the exciting work being done under the REGENERAR initiative.
Sweden’s Single Technologies Progresses Towards 3D Sequencing, $10 Human Genome

The firm has come up with a design for a 3D “matrix” to replace the traditional 2D flow cell, which it says can maximize use of reagents, leading to lower costs. Pairing that with its imaging technology, which it claims could become thousands of times faster than confocal imaging, CEO Johan Strömqvist said the firm might one day sequence a human genome for approximately $10.
Consortium Meeting of REGENERAR in Coimbra

The first consortium meeting of the REGENERAR project happened on March 22. Regenerar, led by the University of Coimbra (UC), is a pioneering project aiming to revolutionize the treatment landscape for neurological diseases by harnessing cutting-edge epigenetic editing techniques. With a substantial funding injection of approximately three million euros from the European Commission’s Pathfinder Open program
Three million euros fund research led by the University of Coimbra to develop new technology to regenerate the brain

Over the next four years, a European research consortium, led by the University of Coimbra (UC), will develop an innovative technology that could boost the regeneration of neurons in diseases that currently have limited therapeutic options. To do this, the scientists will use epigenetic tools to try to convert brain cells in patients into functional neurons. This research could pave the way for improved treatment of health problems such as stroke or neurodegenerative diseases (pathologies that are linked to the nervous system, affecting movement and causing loss of neurological functions).